易緯集團(03893.HK)年度收入7380萬港元 同比增加約53.8%
格隆匯9月30日丨易緯集團(03893.HK)公吿,截至2024年6月30日止年度業績,集團的收入、毛利及虧損淨額分別約為7380萬港元、約1480萬港元及約1300萬港元,與上年度相比收入增加約53.8%,毛損轉為毛利,以及虧損淨額減少約75.7%。
年度綜合淨虧損減少主要歸因於:(a)年度撥回累計合約成本約580萬港元及撥回虧損合約預期虧損約640萬港元,故毛損轉為毛利;(b)本年度物業、廠房及設備減值虧損減少約810萬港元;(c)年度錄得提前終止租賃收益約460萬港元;(d)年度行政開支減少約910萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.